Secondary tier assays like Pig-a offer significant value both for understanding a compound’s mode of action and for following up on a positive in vitro genetic toxicology assay.
North American Genetic Toxicology Workshop
Learn how to successfully execute Genetic toxicology testing, satisfying regulatory criteria and smoothing your path to market.
Additional Support and Regulatory Follow-Up
- This assay is used for scoring the frequency of mutant phenotype erythrocytes (RBCs) and mutant phenotype immature erythrocytes (reticulocytes, or RETs) by measuring the induction of mutations at the Pig-a gene.
- Mutations in the Pig-a gene can prevent production of glycosylphosphatidylinositol (GPI) anchor proteins on the cell surface. Thus, cells without these cell surface markers represent a reliable phenotypic marker of Pig-a mutation.
- Easily integrates into standard toxicity studies
- Provides fast, quantifiable results via flow cytometry
- Uses very low volumes of blood
- 3Rs compliant
- Replaces transgenic rodent mutation assays
When to Perform
- IND-enabling studies
- To determine mutagenic potential
- Additional support
- To assess mutagenicity potential when the Ames assay is not appropriate (e.g., test item is toxic to bacteria)
- Follow-up on a positive result in the Ames assay
- Additional information for compounds with predicted mutagenic properties